*Eye Center Spreebogen, Berlin and Berlin Eye Research Institute (BERI), Berlin †Augencentrum Porz, Koln §Augen-Tagesklinik Gross Pankow, Gross Pankow, Germany ‡Ophthalmic Consultants of Boston, Boston, MA ∥Minnesota Eye Consultants, Minneapolis, MN ¶Grutzmacher & Lewis, Sacramento, CA.
J Glaucoma. 2015 Mar;24(3):187-94. doi: 10.1097/IJG.0b013e318285ff13.
To report 3-year results evaluating the effect on safety and efficacy of canaloplasty to treat open-angle glaucoma when combined with cataract surgery.
This was a retrospective subset analysis of a prospective, international, multicenter study evaluating 133 eyes of 133 adult, open-angle glaucoma patients who underwent canaloplasty with tensioning suture placement. Eighty-two phakic eyes that received canaloplasty alone were compared with 51 eyes that underwent cataract surgery before or during canaloplasty.
Phakic eyes that received combined cataract-canaloplasty surgery (phacocanaloplasty) had a mean±SD baseline IOP of 23.5±5.2 mm Hg and mean glaucoma medication usage of 1.5±1.0 decreasing to a mean IOP of 13.6±3.6 mm Hg on 0.3±0.5 medications at 3 years postoperatively. Pseudophakic eyes undergoing canaloplasty had a mean baseline IOP of 23.9±5.2 mm Hg on a mean of 1.8±0.8 glaucoma medications decreasing to 15.6±3.5 mm Hg on 1.1±0.8 medications at 3 years. In phakic eyes, reductions in IOP were significantly greater and less postoperative IOP lowering medication was needed after undergoing phacocanaloplasty compared to eyes which had canaloplasty alone.
Clear corneal phacoemulsification performed before or in combination with canaloplasty is a safe and effective surgical procedure to reduce IOP in adult patients with open-angle glaucoma.
报告评估青光眼引流管植入术联合白内障手术治疗开角型青光眼的 3 年安全性和疗效的结果。
这是一项前瞻性、国际、多中心研究的回顾性亚组分析,共纳入 133 例成年开角型青光眼患者的 133 只眼,这些患者均接受了带缝线的青光眼引流管植入术。82 只单纯白内障眼与 51 只白内障术前或术中接受青光眼引流管植入术的眼进行比较。
接受白内障青光眼引流管联合手术(白内障青光眼引流管植入术)的白内障眼术前平均眼压(IOP)为 23.5±5.2mmHg,平均使用 1.5±1.0 种降眼压药物,术后 3 年时平均眼压为 13.6±3.6mmHg,用药 0.3±0.5 种。单纯接受青光眼引流管植入术的无晶状体眼术前平均 IOP 为 23.9±5.2mmHg,平均使用 1.8±0.8 种降眼压药物,术后 3 年时平均眼压为 15.6±3.5mmHg,用药 1.1±0.8 种。白内障青光眼引流管植入术后眼压降低幅度明显更大,术后需要的降眼压药物也更少。
对于成年开角型青光眼患者,透明角膜超声乳化白内障吸除术联合或不联合青光眼引流管植入术是一种安全有效的降低眼压的手术方法。